Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$16.32 - $26.37 $16,320 - $26,370
-1,000 Reduced 83.33%
200 $4,000
Q2 2022

Aug 15, 2022

BUY
$18.54 - $37.29 $22,248 - $44,748
1,200 New
1,200 $24,000

Others Institutions Holding ALBO

About ALBIREO PHARMA, INC.


  • Ticker ALBO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,612,500
  • Description
  • Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...
More about ALBO
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.